FDA Inspection 1115960 — Bristol-Myers Squibb Company
The FDA completed an inspection of Bristol-Myers Squibb Company on January 10, 2020 in Devens, MA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- January 10, 2020
- Fiscal Year
- 2020
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Devens, MA (United States)